Applied Genetic (AGTC) Financials

$0.39

$0.00 (0.00%)

As on 09-Dec-2022 09:30EDT

Market cap

$27 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Operating Revenue	0.33	0.33	0.50	2.45	41.69	24.19
Cost of Revenue	--	--	--	--	13.83	15.37
Gross Profit	--	--	--	2.45	41.69	24.19
Operating Expenses	67.42	66.50	58.95	49.40	46.04	46.57
Operating Profit (EBIT)	-67.09	-66.18	-58.45	-46.94	-4.35	-22.38
Other Income	--	--	--	1.13	2.42	1.16
Profit before Tax	-70.00	-68.75	-59.84	-45.76	-1.90	-21.21
Provision for Tax	-68.85	-68.85	-2.11	0.08	0.08	0.07
Profit after Tax (Net Income)	-70.23	-68.94	-57.83	-45.89	-2.01	-21.30
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-70.23	-68.94	-57.83	-45.89	-2.01	-21.30

Liabilities ($ Mln)	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Shareholder's Funds	17.65	29.48	85.81	71.02	78.71	99.18
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	13.08	12.00	21.44	16.34	4.15	4.96
Current Liabilities	26.60	25.21	19.71	12.96	9.36	14.40
Total Liabilities	26.60	66.68	126.97	100.32	92.22	118.53

Assets ($ Mln)	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Non-Current Assets	20.09	17.12	17.26	17.36	7.93	9.41
Current Assets	37.24	49.56	109.71	82.96	84.28	109.12
Total Assets	83.94	66.68	126.97	100.32	92.22	118.53
Total Debt*	--	22.47	24.48	10.78	--	--
Net Current Assets	10.64	24.35	89.99	70.00	74.93	94.73

Cashflow ($ Mln)	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Cash From Operating Activities	--	-65.75	-51.17	-41.62	-23.46	-32.52
Cash Flow from Investing Activities	--	-0.01	38.15	8.40	19.03	33.02
Cash from Financing Activities	--	7.08	79.62	44.98	0.07	-0.14
Net Cash Inflow / Outflow	--	--	--	11.76	-4.36	0.36

Financials Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Adjusted EPS ($)	-1.46	-1.53	-1.75	-2.19	-0.11	-1.18
Cash EPS ($)	--	-1.50	-1.71	-2.12	-0.04	-1.12
Adjusted Book Value ($)	--	0.66	2.60	3.38	4.37	5.51
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.46	-1.55	-1.98	-1.30	-1.81
Free Cash Flow per Share ($)	--	-1.51	-1.61	-2.04	-1.32	-1.85

Profitability Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
ROCE (%)	--	-84.99	-60.21	-57.18	-2.26	-19.86
ROE (%)	-217.20	-119.60	-73.75	-61.30	-2.26	-19.86
ROA (%)	-65.01	-71.20	-50.89	-47.67	-1.90	-15.99
EBIT Margin (%)	-21,080.92	-20,390.46	-11,686.20	-1,867.47	-4.63	-87.77
Net Margin (%)	-21,610.46	-21,213.23	-11,565.80	-1,279.75	-4.55	-84.05
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Revenue Growth (%)	-35.00	-0.35	-0.80	-0.94	0.72	-0.39
EBIT Growth (%)	-14.47	-13.41	-27.55	-2,273.52	90.91	-856.25
Net Profit Growth (%)	-17.91	-19.22	-26.01	-2,187.74	90.58	-5,333.42
EPS Growth (%)	17.03	0.13	0.20	-18.61	0.91	-53.33
Book Value Growth (%)	-83.21	--	--	--	--	--

Valuation Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Price / Earnings	--	-0.50	-2.23	-2.54	-34.01	-3.13
Price / Book Value	1.51	1.18	1.50	1.64	0.87	0.67
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.19	-0.17	-0.82	-1.05	20.97	1.91
Close Price ($)	0.27	0.77	3.91	5.54	3.79	3.70
High Price ($)	3.18	4.15	9.67	10.42	7.50	5.75
Low Price ($)	0.27	0.58	3.53	2.29	2.26	3.25
Market Cap ($ Cr)	26.62	--	--	--	--	--

Solvency Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Debt to Equity	0.39	0.76	0.29	0.15	--	--
Short term debt to equity ratio	--	0.36	0.04	0.02	--	--
Current Ratio	1.40	1.97	5.56	6.40	9.01	7.58
Quick Ratio	1.40	--	--	--	--	7.58
Interest Coverage	-25.29	-24.78	-38.80	--	--	--

Operating Efficiency Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Debtors to sales (%)	--	--	--	--	0.03	0.87
Asset Turnover	0.00	0.00	0.00	0.03	0.40	0.18
Receivable days	--	--	--	0.97	0.98	2.90
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	30.06	23.09
Cash Conversion Cycle	--	--	--	--	-29.08	-20.19

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.